FDA Inspection 1007326 — Pfizer Ireland Pharmaceuticals Unlimited Company
The FDA completed an inspection of Pfizer Ireland Pharmaceuticals Unlimited Company on March 10, 2017 in Dublin 22. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 10, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 22 (Ireland)
Citations
| ID | CFR | Description |
|---|---|---|
| 3602 | 21 CFR 211.160(a) | Deviations from laboratory control requirements |